Biogen (BIIB) Construction in Progress (2009 - 2025)

Biogen's Construction in Progress history runs 17 years deep, the most recent figure standing at $163.1 million for Q4 2025.

• In Q4 2025, Construction in Progress fell 47.11% year-over-year to $163.1 million; the TTM figure through Dec 2025 stood at $163.1 million (down 47.11% YoY), while the FY2025 annual figure was $163.1 million, down 47.11% from the prior year.
• Construction in Progress was $163.1 million for Q4 2025 at Biogen, down from $308.4 million in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $1.9 billion in Q1 2021 to a low of $163.1 million in Q4 2025.
• Historically, Construction in Progress has averaged $754.1 million across 5 years, with a median of $711.1 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Construction in Progress climbed 15.38% in 2022, then tumbled 68.38% in 2024.
• A 5-year view of Construction in Progress shows it stood at $770.3 million in 2021, then rose by 15.38% to $888.8 million in 2022, then climbed by 9.74% to $975.4 million in 2023, then slumped by 68.38% to $308.4 million in 2024, then sank by 47.11% to $163.1 million in 2025.
• The last three Construction in Progress figures came in at $163.1 million (Q4 2025), $308.4 million (Q4 2024), and $975.4 million (Q4 2023), per Business Quant data.